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Abstract
Our understanding of the composition of multi-clonal malarial infections and the epidemiological factors which shape their
diversity remain poorly understood. Traditionally within-host diversity has been defined in terms of the multiplicity of
infection (MOI) derived by PCR-based genotyping. Massively parallel, single molecule sequencing technologies now enable
individual read counts to be derived on genome-wide datasets facilitating the development of new statistical approaches to
describe within-host diversity. In this class of measures the FWS metric characterizes within-host diversity and its relationship
to population level diversity. Utilizing P. falciparum field isolates from patients in West Africa we here explore the
relationship between the traditional MOI and FWS approaches. FWS statistics were derived from read count data at 86,158
SNPs in 64 samples sequenced on the Illumina GA platform. MOI estimates were derived by PCR at the msp-1 and -2 loci.
Significant correlations were observed between the two measures, particularly with the msp-1 locus (P=5.92610
25). The
FWS metric should be more robust than the PCR-based approach owing to reduced sensitivity to potential locus-specific
artifacts. Furthermore the FWS metric captures information on a range of parameters which influence out-crossing risk
including the number of clones (MOI), their relative proportions and genetic divergence. This approach should provide
novel insights into the factors which correlate with, and shape within-host diversity.
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Introduction
Particularly in high transmission regions, individuals may carry
multiple genetically distinct parasite clones in a single malaria
infection (multi-clonal infection). This dynamic poses numerous
challenges to malaria control. Recombination between genetically
distinct parasite clones (out-crossing) is a major risk factor for
generating novel parasite variants with clinically important
phenotypes such as virulence, drug resistance or immune evasion.
Parasite diversity dynamics also have important implications for
host immune acquisition, and influence the selection and spread of
drug resistance [1,2,3,4,5]. Furthermore, the intense competition
enabled between distinct clones within an infection appears to
promote the evolution of highly virulent Plasmodium parasites
[6,7,8,9]. Numerous studies have sought correlations between
parasite multi-clonality and clinical phenotypes such as patient
age, immune status, clinical outcome, drug sensitivity, gametocyte
production and gametocyte infectivity [10,11,12,13,14,15,16,17].
However, these studies have been constrained by the limited
availability of tools to effectively gauge the genetic composition of
multi-clonal infections. Constrained in part by these limitations we
still have only a poor understanding of how within-host diversity is
shaped in different epidemiological settings.
Our current understanding is that multi-clonal infections may
be generated by super-infection (the composition of multiple
infectious bites with genetically distinct clones), and that this may
be a frequent occurrence in high transmission areas. However, it
has also been demonstrated that a single mosquito inoculation
may carry a large amount of parasite diversity [18], and that this
again may be dependent on the population level diversity. In
addition, within-host dynamics may be shaped by factors such as
host immunity and density-dependent control mechanisms [19].
In order to better understand the dynamics of multiple-clone
infections and parasite out-crossing, effective tools to address
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diversity are essential.
Traditionally, within-host parasite diversity has been described
by the number of distinct clones within an infection, or,
multiplicity of infection (MOI). A common approach is the use
of PCR to derive the number of repeat length variants observed at
a few highly diverse loci, most frequently variable number tandem
repeats (VNTRs) in the genes encoding antigens such as the
merozoite surface protein 1 (MSP1) and 2 (MSP2) [20,21]. The
large repertoire of alleles at a single VNTR locus is practical for
finger-printing malaria parasites, particularly for drug surveillance.
However, limitations on the number and ‘‘nature’’ of the loci
constrain effective characterization of within-host diversity.
Furthermore, as the clone counting approach does not account
for the population level of diversity, limited insight is gained into
the risks of out-crossing in a given population.
Massively parallel sequencing technologies now enable charac-
terization of parasite diversity at high depth and molecular
resolution [22,23,24]. Individually, SNPs do not capture as much
diversity as VNTRs, and so the clone counting MOI method is not
effective for SNP data. Alternatively, the single molecule
sequencing approach of platforms such as the Illumina Genome
Analyzer enables individual allele counts to be derived at each
SNP position, and the opportunity for new statistical approaches
to describe within-host parasite diversity based on population
genetics such as the FWS metric (Manske, Miotto et al., in
preparation). This metric characterizes not just within-host
diversity, but also its relationship to local population diversity,
essentially measuring the risk of out-crossing/inbreeding.
Here, using PCR at the msp1 and 2 loci, we explore the
relationship between the traditional VNTR-based MOI and
genome-wide, SNP-based FWS metric in clinical (non-cultured)
Plasmodium falciparum samples from malaria-endemic regions in
West Africa.
Results and Discussion
PCR-based estimation of MOI
The traditional method for characterizing within-host diversity in
P. falciparum entails MOI estimation using genotype data from the
msp-1 and -2 loci [20]. This approach utilizes family specific and
repeat length variants in each gene to differentiate parasite clones
(see Methods). In the West African samples, genotyping success rates
at the msp-1 and -2 loci were 100% (64/64) and 98% (63/64),
respectively. The distributions of MOI estimates for each assay/
population are presented in Figure S1. A summary of these
distributions is presented in Table 1. MOI estimates were slightly
higher in Burkina Faso (mean=2.95) than Mali (mean=2.57), but
the difference was not significant (t=1.28, P=0.209). These
estimates are similar to previous observations in Mali and Burkina
Faso [25,26]. In the combined population (West Africa), the mean
MOI estimate was 2.83. The gene-specific MOI estimates
demonstrated similar distributions to the maximum MOI (Figures
S2, 3), although msp-2 estimates (mean=2.54) were moderately
higher than msp-1 (mean=2.19) (t=21.82; P=0.071). Moderate
gene-specific differences were also observed between populations.
The msp-1 MOI estimates were higher in Burkina Faso
(mean=2.33) than Mali (mean=1.90), with borderline significance
(t=1.94,P=0.059).Themsp-2MOIestimateswereonlymoderately
higher in Burkina Faso (mean=2.64) than Mali (mean=2.33), and
the difference was not significant (t=0.91, P=0.368). In summary,
the MSP MOI data indicated high multi-clonality in West Africa,
with slightly higher levels in Burkina Faso than Mali, and subtle
differences in the estimates derived from the msp-1 and -2 loci.
Genome-wide characterization of within-host diversity
(FWS)
The FWS metric describes the relationship between the diversity
observed within a patient to that of the population using
estimations of heterozygosity (i.e. the probability that two
randomly selected parasites carry different alleles at a given locus).
In any given population, heterozygosity is dependent on the allele
frequencies at that locus, as described by the Hardy-Weinberg
principle, and is therefore influenced by the level of out-crossing in
the population. By combining allele counts across all samples in
the population, we can derive an estimate of population allele
frequencies at each locus, and consequently estimate heterozygos-
ity at the population level (HS). Similarly, for each sample, using
allele counts at each locus, we can estimate within-host
heterozygosity (HW), enabling computation of the FWS measure.
Essentially, the FWS metric provides a measure of the risk of out-
crossing between the parasites within an individual to generate
new genotypes during recombination in the mosquito host. Thus,
the metric captures information on all of the sample parameters
which influence the risk of new parasite genotypes being generated
at meiosis. These include not just the overall diversity within an
individual but also the level of similarity between the parasites and
their relative proportions. A low FWS reflects a low risk of
inbreeding/high risk of out-crossing and thus high within-host
diversity. Whilst simple calculations of the heterozygosity at each
locus within a sample provide some level of information on within-
host diversity, the ability to describe this diversity in the context of
the level of diversity in the population is critical to capturing
information on the risk of out-crossing. Consequently, population
level heterozygosity estimates are essential for effective computa-
tion and interpretation of the FWS metric.
We previously described FWS distributions in a range of P.
falciparum populations, demonstrating global patterns of within-host
diversity consistent with our knowledge of the epidemiology and
human (and parasite) migration patterns in the regions studied
(Manske, Miotto et al., in preparation). In the West African samples
addressed here, a mean FWS of 0.73 was observed, with 28%
samples exhibiting ‘‘high’’ FWS estimates (i.e. $0.95: see Figure S2).
In each of Mali and Burkina Faso, the mean FWS scores were 0.81
Table 1. Summary of MOI and FWS estimates in Burkina Faso, Mali and the combined (West Africa) population.
Burkina Faso Mali All (West Africa)
Mean Maximum MOI (range) 2.95 (1–5) 2.57 (1–4) 2.82 (1–5)
Mean MSP1 MOI (range) 2.33 (1–4) 1.91 (1–4) 2.19 (1–4)
Mean MSP2 MOI (range) 2.64 (1–5) 2.33 (1–4) 2.54 (1–5)
Mean FWS (range) 0.69 (0.19–1.00) 0.81 (0.32–1.00) 0.73 (0.19–1.00)
doi:10.1371/journal.pone.0032891.t001
PF-Within-Host-Diversity
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proportion of samples with high FWS scores is indicative of a large
degree of panmixis (low sub-structure) amongst the parasites in the
populations sampled here. Presumably, super-infection with
genetically distinct parasites is a relatively frequent occurrence. It
follows that the risks of parasite out-crossing, and consequent threat
to malaria control efforts, are moderately high in these populations.
In accordance with the msp-based results, greater within-host
diversity (lower FWS) was observed in Burkina Faso (mean=0.69)
than Mali (mean=0.81) (t=22.08, P=0.042). This observation
may reflect subtle differences in the epidemiology of the sites studied
here, such as rural (Mali) versus urban (Burkina Faso) influences on
transmission dynamics [27,28]. Further exploration of the FWS
profileindifferentepidemiologicalsettingsisrequiredtoaddressthis
and other putative determinants of within-host parasite diversity.
This should also enable more effective interpretation of the relative
out-crossing risks associated with different FWS scores.
>A wide range of FWS scores were observed in the West African
populations (Figure S2). Thus, even after gauging within-host
diversity estimates in terms of the out-crossing risk and related
parameters (number, relative proportion, and degree of divergence
between clones), there appears to be heterogeneity in within-host
diversity in the West African populations. It remains to be
determined how well this heterogeneity reflects the heterogeneity in
clinical outcomes such as disease severity, gametocyte prevalence
and infectivity, patient age and immune status, in West Africa and
other populations. To date, the parasite genetic basis of these
outcomes has generally only been addressed with regard to clone
count measures of within-host diversity (review in [29]). The extent
to which the clone counting MOI approach reflected the additional
diversity parameters captured by the FWS metric remained
uncertain. We therefore explored this relationship further.
Relationship between genome-wide FWS metric and
MSP1+MSP2 MOI estimates
Using the FWS score as a proxy to genome-wide within-host
SNP diversity, we assessed the correlation between this metric and
the MSP-based MOI estimates. A significant negative correlation
was observed between the MSP1 MOI and FWS (rho=20.480,
P=5.92610
25), as illustrated in Figure 1. The FWS correlations
with each of the MSP2 and maximum MOI estimates were less
strong but both remained significant (rho=20.366, P=0.003;
rho=20.384, P=0.002, respectively) (Figure 1). These correla-
tions demonstrated that the MOI and FWS metric broadly agreed
on their interpretations of within-host diversity. However,
differences in two key areas, 1) the analytical approach, and 2)
the number and nature of loci examined, may underlie the
remaining deviations between the two measures.
A moderate proportion of samples (13/64 [20.3%]) demon-
strated multiple clones by MSP genotyping but appeared to be
largely ‘‘clonal’’ with respect to the FWS ($0.95). These results
presumably reflect infections with multiple clones exhibiting
limited divergence and thus limited within-host diversity. As
detailed below, any of a number of differences, both technical and
analytical, between the PCR-based MOI and FWS approaches
may underlie these discrepancies. Fewer samples (4/64 [6.25%])
exhibited a clonal MSP outcome concurrent with high diversity
FWS (#0.70). The ability to capture the relatedness between the
clones within an infection should facilitate our understanding of
the impact of within-host regulatory effects such as inter-parasite
competition and host immunity on parasite diversity dynamics.
In addition to the core analytical approach, the PCR-based
MOI approach may be constrained in ability to capture the
complexity of an individual infection owing to sensitivity to the
number of loci examined, the level of polymorphism at each locus,
family-specific versus intra-family variation and selective pressures
at one or more loci. In these respects, the genome-wide, SNP-
based, FWS approach is more robust. In general, even with highly
diverse loci, more markers ensure a more accurate representation
of diversity [30]. Indeed, a larger number of multiple clone
infections were detected by the maximum MOI (92% [59/64])
than with the msp-1 (79% [50/63]) and -2 (77% [49/64]) loci
individually. However, practicalities limit the number of loci that
can be examined by PCR.
Owing to differences in the level and nature of polymorphism,
inter-locus variation in diversity is not unexpected within a multi-
clonal malaria infection. Indeed, the msp-1 and -2 genes exhibited
modest differences in polymorphism, reflected in their different
strengths of correlation with the FWS metric (Figure 1). Inter-locus
differences may also result from locus-specific selective pressures
which are not representative of the genome as a whole. This is a
potential limitation of MSP1 and 2, which appear to be under
selective pressure from the host immune system [31].
The distinction of alleles at VNTR loci by electrophoretic
mobility is another potential limitation of the PCR-based approach,
as differences in sequence composition between equally migrating
fragments may be missed. Furthermore, it is generally accepted that
VNTRs evolve at different rates and under different mechanisms
from SNPs [32,33,34,35]. Thus, VNTRs may not provide an
effective representation of the SNP diversity in the genome. Rather,
as observed with the moderately high frequency (20.3%) of isolates
demonstrating largely clonal dynamics with FWS estimates but
polyclonal dynamics at the MSP loci, VNTR-based estimates may
overestimate the true genome-wide within-host diversity.
A potential shortfall of the FWS approach is the integrity of the
genome-wide dataset. A highly stringent SNP discovery and allele-
calling process was employed here to ensure high confidence in the
dataset (see Methods). In addition, only good quality samples with
high sequence depth were included (Figure S3). The comparable
sensitivity of the PCR-based and genome-sequencing approach
has yet to be determined. However, in contrast to the potential
ambiguity in detecting and distinguishing bands on gels, the ability
to count individual reads in Illumina sequence data enables more
objective allele-calling.
Juliano and colleagues achieved extensive sequence depth at the
msp-1 and -2 loci by focusing 454 sequencing on amplicons of
these two genes alone [36]. Using the clone-counting approach,
facilitated by haplotype information, an average of ,5 more msp-1
and -2 variants were detected relative to the genotyping data. As
with the PCR-based MOI method, this approach is powerful for
distinguishing clones in clinical drug trials. For characterization of
within-host diversity however, the use of just 2 VNTR loci under
potential selective pressure renders this approach sensitive to the
features discussed above. With continual improvements in read
length and sequence yield on high-throughput, single-molecule
sequencing platforms, haplotype-based clone counting approaches
similar to those described by Juliano and colleagues should be
feasible on a broader, genome-wide, scale.
Conclusion
The traditional approach to estimating MOI using VNTRs at a
handful of loci such as msp-1 and -2 is a simple and moderately
cheap method with demonstrated practicality for finger-printing
clones in drug trials. However, genome-wide measures such as the
FWS statistic, by capturing information not just on the number of
clones in a sample but also on their respective ratios and the degree
of inter-clone variation at hundreds of thousands of polymorphic
positions, provide a greater wealth of information on within-host
PF-Within-Host-Diversity
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artifacts. With rapidly advancing progress in whole genome
sequencing technologies, including ever increasing read lengths
and continual reductions in cost, this approach is now feasible in
hundreds of samples. The ability to assess within-host diversity in
genome-wide datasets from non-cultured (clinical) samples sourced
from low resource field settings, as demonstrated here, should
revolutionize clinical and epidemiological studies of Plasmodium.
Methods
Samples
Samples were collected from field sites in Mali and Burkina Faso
within the framework of a large, multi-center P. falciparum genome
sequencing project to facilitate SNP discovery and population genetic
characterization (Manske, Miotto et al., in preparation). Consenting
patients of all ages and ethnic groups presenting at the clinic with
symptoms of uncomplicated malaria and P. falciparum parasitaemia
were recruited to the study. In Mali, samples were collected from
clinics in two rural villages (Kolle and Faladje). In Burkina Faso,
samples were collected from permanent health dispensaries in three
suburbs of Bobo-Dioulasso (Colsamma, Ouezzinville, and Sakaby).
Details of the sample processing procedures in the laboratory are
described elsewhere [37]. Briefly, venous blood (2–8 ml) was
processed to deplete the human white blood cell fraction, and
DNA extraction was undertaken using Qiagen QIAamp blood
extraction kits as per the manufacturer’s instructions.
Ethics
Informed, written consent was obtained from patients over 18
years of age and from a parent or guardian for younger patients.
The study was approved by the Comite d’Ethique de la Faculte ´d e
Figure 1. FWS against MSP1 MOI, MSP2 MOI, and maximum MOI.
doi:10.1371/journal.pone.0032891.g001
PF-Within-Host-Diversity
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and Comite d’Ethique Institutionnel du Centre Muraz, Bobo-
Dioulasso, Burkina Faso.
Sequencing and SNP Calling
Sixty-four samples (21 Mali, 43 Burkina Faso) with .500 ng
total DNA and ,60% human DNA contamination were
sequenced on the Illumina Genome Analyzer platform. Details
of the sequencing, SNP discovery and genotype calling process are
described elsewhere (Manske, Miotto et al., in preparation). Briefly,
up to 6 lanes were sequenced per sample, with 37, 54 or 76 bp
paired-end reads. Coverage distributions are presented in Figure
S3. The ‘‘raw’’ sequence data for the samples can be accessed in
the European Nucleotide Archive (www.ebi.ac.uk/ena/data/
search/?query=plasmodium). For each sample, sequence data
from multiple lanes was merged, and mapped to the P. falciparum
reference genome (3D7 version 2.1.5; ftp://ftp.sanger.ac.uk/pub/
pathogens/Plasmodium/falciaprum/3D7/3D7.version2.1.5) us-
ing the bwa program (available from http://bio-bwa.sourceforge.
net) with the default parameters [38]. The resulting alignments
were processed in samtools (http://samtools.sourceforge.net/cns0.
shtml) using the default parameters to identify positions with one
or more bases differing from the reference sequence (putative SNPs).
Genotypes were called at 86,158 high confidence SNP positions
(typable SNPs) identified by a stringent quality-filtering SNP
discovery process detailed elsewhere (Manske, Miotto et al.,i n
preparation). This SNP list is referred to as version 1gamma and is
available on the MapSeq database (www.mapseq.net/pf). For the
purpose of assigning confident genotype calls to the dataset, all
genotypes in the version 1 gamma dataset with less than 5 reads
were assigned a status of missing data.
Calculation of FWS
Details of the underlying basis for calculations used to derive the
Fws metric are described elsewhere (Manske, Miotto et al.,i n
preparation). The FWS metric was calculated for each individual
sample, using the formula FWS=12(Hw/Hs), where Hw is the
within-individual heterozygosity and Hs is the within-population
heterozygosity. At each biallelic SNP, heterozygosity was estimat-
ed using the formula H=12(p
2+q
2), where p and q are the
frequencies of the two alleles (p=12q). At each SNP, p and q were
estimated for each individual as the proportions of sequencing
reads that carried each allele in the individual sample. At
population level, the allele frequencies at the SNP were estimated
as the mean of the allele frequencies in the individuals comprising
the population sample; the frequency of the least common allele at
that SNP in the West African population was noted as the minor
allele frequency (MAF). Since heterozygosity depends on allele
frequencies, each of the 86,158 SNPs was assigned to one of ten
equally-sized MAF intervals ([0.0–0.05], [0.05–0.1] … [0.45–0.5]).
Estimates of Hw and Hs were calculated for each MAF interval, as
the means of the Hw and Hs across all SNPs in that interval. For
each individual, Hw estimates were plotted against the corre-
sponding Hs estimates for all MAF intervals, and the slope of the
resulting straight-line plot was used to evaluate the Hw/Hs ratio,
and thus compute FWS for the individual.
Genotype-based MOI Estimation
The traditional method of genotyping in the P. falciparum
merozoite surface protein - 1 (msp-1) and -2 (msp-2) genes was
undertaken on 64 of the typable samples using a nested PCR
approach [20]. This method utilises family specific variation and
variation in repeat length in each gene to distinguish parasite
clones. In general, each parasite will exhibit one of three family-
specific sequences, K1, R033 or MAD20, in the msp-1 gene, and
one of two family-specific sequences, FC27 or IC/3D7, in the msp-
2 gene. Within each family-specific sequence, regions comprising
repeat-length polymorphisms enable further distinction of clones.
The number of distinct bands observed in each sample was
summed across the families in each of the msp-1 and -2 genes
separately, providing gene-specific MOI estimates. The maximum
MOI estimate was then derived as the maximum gene-specific
MOI estimate for each sample. The standard Welch two-sample t-
test was used to measure the significance of difference in MOI
estimates between populations and assays using R software.
Supporting Information
Figure S1 MSP-based MOI Estimates.
(TIFF)
Figure S2 Distribution of Fws scores in the West African
samples. Dashed lines indicate thresholds for highly diverse
(Fws#0.7) and moderately ‘‘clonal’’ (Fws$0.95) samples.
(TIFF)
Figure S3 Read depth distribution at the typable SNP
positions in the West African samples. Distribution of SNP
coverage at read depth (number of sequenced nucleotides covering
a given locus) thresholds of 1, 5, 10, 15, 20 and 25.
(TIFF)
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